The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
15 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,123,623 in first-year total cost, median $300,000.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IMST-H (15)]6
- Special Emphasis Panel[ZRG1 IMST-F (15)]2
- Special Emphasis Panel[ZRG1 OTC-H (13)]2
- Special Emphasis Panel[ZRG1 BCMB-G (10)]1
- Special Emphasis Panel[ZRG1 IMST-F (10)]1
Most frequent institutions
- AMBERGEN, INC2
- ALPENGLOW BIOSCIENCES, INC.1
- CLAREMONT BIOSOLUTIONS, LLC1
- COMBINATI, INC.1
- D2G ONCOLOGY, INC.1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring1R44CA261523-01 | HUNG, PAUL JU-SUNG | COMBINATI, INC., CA | $772,720 | ZRG1 |
| 2021 | Capture and Characterization of Highly Metastatic Cancer Cell Clusters in Transit from Lung Cancer Patient Whole Blood Specimens.1R43CA261362-01 | ALLEN, JEFFREY KEITH | TUMORGEN, INC., CA | $393,048 | ZRG1 |
| 2020 | Relating Drugs to Genotypes to Transform Precision Cancer Therapeutics with Tuba-seq - a Novel, Highly Scalable and Quantitative Preclinical Experimental Oncology Platform1R44CA250672-01 | WINTERS, IAN PAUL | D2G ONCOLOGY, INC., CA | $1,134,487 | ZRG1 |
| 2020 | Spatial and single cell analysis of tumor microenvironment by seqFISH+1R44CA247353-01 | FRIEDA, KIRSTEN | SPATIAL GENOMICS, INC., CA | $999,999 | ZRG1 |
| 2020 | N6-Methyl-2'-O-Methyladenosine Sequencing1R43CA243757-01A1 | ERVIN, ERIC | ELECTRONIC BIOSCIENCES, INC., CA | $400,000 | ZRG1 |
| 2020 | Open-top light-sheet microscopy for non-destructive 3D pathology of prostate biopsies1R43CA250885-01A1 | REDER, NICHOLAS | ALPENGLOW BIOSCIENCES, INC., WA | $397,742 | ZRG1 |
| 2020 | New specific and rapid assay for in situ apoptosis labeling for cancer studies1R43CA250805-01 | WANG, SHA | VIVID TECHNOLOGIES, TX | $214,214 | ZRG1 |
| 2019 | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues2R44CA236097-02 | LIM, MARK | AMBERGEN, INC, MA | $999,744 | ZRG1 |
| 2019 | Allele selective enrichment for targeted profiling of rare cancer mutations via low-depth sequencing1R43CA236103-01 | KHODAVERDIAN, VARANDT Y. | NUPROBE USA, INC., TX | $300,000 | ZRG1 |
| 2019 | Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis1R43CA239967-01 | BROWN, MARK T | CLAREMONT BIOSOLUTIONS, LLC, CA | $299,988 | ZRG1 |
| 2019 | SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples1R43CA236177-01 | KASOJI, SANDEEPPATTENDEN, SAMANTHA GAIL | TRIANGLE BIOTECHNOLOGY, INC., NC | $298,529 | ZRG1 |
| 2019 | Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations1R43CA236167-01A1 | OZERS, MARY SZATKOWSKIWARREN, CHRISTOPHER L | PROTEOVISTA, LLC, WI | $224,527 | ZRG1 |
| 2018 | Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues1R43CA236097-01 | LIM, MARK | AMBERGEN, INC, MA | $300,000 | ZRG1 |
| 2018 | Molecular Beacons in Lipoplex Nanoparticles for Extracellular Vesicles Based Cancer Diagnosis1R43CA236101-01 | KWAK, KWANG JOOLEE, LY JAMES | NANOMATERIAL INNOVATION, LTD, OH | $238,625 | ZRG1 |
| 2018 | Origami Nanoprobes for Large-Scale Single-Cell Analysis of Lymphocytes1R43CA236142-01 | BLATTMAN, JOSEPH NSCHOETTLE, LOUIS | GEMNEO BIOSCIENCE, INC., AZ | $150,000 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.